Jeff Pavell

Jeff Pavell

Net worth: 5 075 $ as of 29/06/2026

59 year
Health Services
Health Technology
Consumer Services

Profile

Jeff Pavell is currently an Independent Director at Silo Pharma, Inc. since 2022, an Independent Director at Rocket One, Inc. since 2022, an Independent Director at FoxWayne Enterprises Acquisition Corp.
since 2021, Associate Director-Pain Medicine at Center For Advanced Surgery LLC since 2002, and Chief-Rehabilitation Medicine at Englewood Hospital & Medical Center, Inc. since 2000.
Former roles include Partner at Patient Care Associates, Inc. and Partner at Physical Medicine & Rehabilitation Center PA. Education includes a doctorate from New York College of Osteopathic Medicine and undergraduate studies at John Hopkins University Atlantic Basin Policy Institute.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
25/05/2026 5,075 ( 0.02% ) 5 075 $ 29/06/2026
17/06/2026 0 ( -.--% ) - $ 29/06/2026

Jeff Pavell active positions

CompaniesPositionStart
FOXWAYNE ENTERPRISES ACQUISITION CORP. Director/Board Member 31/12/2020
SILO PHARMA, INC. Director/Board Member 26/09/2022
ROCKET ONE INC. Director/Board Member 06/12/2022
Corporate Officer/Principal 31/12/1999
Corporate Officer/Principal 31/03/2002

Former positions of Jeff Pavell

CompaniesPositionEnd
Corporate Officer/Principal -
Corporate Officer/Principal -
See the detail of Jeff Pavell's experience

Training of Jeff Pavell

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

57

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies9

Health Technology

Health Services

Consumer Services

Consumer Services

Health Services

Health Technology

Finance

Health Services

Health Services